Atypical comorbidities in a child considered to have type 1 diabetes led to the diagnosis of SLC29A3 spectrum disorder

被引:3
|
作者
Besci, Ozge [1 ]
Patel, Kashyap Amratlal [2 ]
Yildiz, Gizem [3 ]
Tufekci, Ozlem [4 ]
Acinikli, Kubra Yuksek [1 ]
Erbas, Ibrahim Mert [1 ]
Abaci, Ayhan [1 ]
Bober, Ece [1 ]
Bayram, Meral Torun [3 ]
Yilmaz, Sebnem [4 ]
Demir, Korcan [1 ]
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Pediat Endocrinol, Izmir, Turkey
[2] Univ Exeter, Inst Biomed & Clin Sci, Exeter, Devon, England
[3] Dokuz Eylul Univ, Fac Med, Dept Pediat Nephrol, Izmir, Turkey
[4] Dokuz Eylul Univ, Fac Med, Dept Pediat Hematol & Oncol, Izmir, Turkey
来源
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2022年 / 21卷 / 03期
基金
英国惠康基金;
关键词
Monogenic diabetes; Anemia; Steroid; Tocilizumab; Intravenous immunoglobulin; PIGMENTED HYPERTRICHOTIC DERMATOSIS; H SYNDROME; GENETIC RISK; MUTATIONS; MELLITUS;
D O I
10.1007/s42000-022-00352-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction SLC29A3 spectrum disorder is an autosomal, recessively inherited, autoinflammatory, multisystem disorder characterized by distinctive cutaneous features, including hyperpigmentation or hypertrichosis, hepatosplenomegaly, hearing loss, cardiac anomalies, hypogonadism, short stature, and insulin-dependent diabetes. Case presentation Herein, we report a 6-year-old boy who presented with features resembling type 1 diabetes mellitus, but his clinical course was complicated by IgA nephropathy, pure red cell aplasia, and recurrent febrile episodes. The patient was tested for the presence of pathogenic variants in 53 genes related to monogenic diabetes and found to be compound heterozygous for two SLC29A3 pathogenic variants (p. Arg386Gln and p. Leu298fs). Conclusion This case demonstrated that SLC29A3 spectrum disorder should be included in the differential diagnosis of diabetes with atypical comorbidities, even when the distinctive dermatological hallmarks of SLC29A3 spectrum disorder are entirely absent.
引用
收藏
页码:501 / 506
页数:6
相关论文
共 6 条
  • [1] Atypical comorbidities in a child considered to have type 1 diabetes led to the diagnosis of SLC29A3 spectrum disorder
    Özge Besci
    Kashyap Amratlal Patel
    Gizem Yıldız
    Özlem Tüfekçi
    Kübra Yüksek Acinikli
    İbrahim Mert Erbaş
    Ayhan Abacı
    Ece Böber
    Meral Torun Bayram
    Şebnem Yılmaz
    Korcan Demir
    Hormones, 2022, 21 : 501 - 506
  • [2] Combination of four features of SLC29A3 spectrum disorder in a child: A case report
    Aslani, Nahid
    Abtahi-Naeini, Bahareh
    Rastegarnasab, Fereshte
    Derakhshan, Maryam
    Tavousi, Elham
    Mehraein, Kimia
    PEDIATRIC DERMATOLOGY, 2024, 41 (05) : 888 - 892
  • [3] A Case of SLC29A3 Spectrum Disorder—Unresponsive to Multiple Immunomodulatory Therapies
    Anoop Mistry
    David Parry
    Bipin Matthews
    Philip Laws
    Mark Goodfield
    Sinisa Savic
    Journal of Clinical Immunology, 2016, 36 : 429 - 433
  • [4] A Case of SLC29A3 Spectrum Disorder-Unresponsive to Multiple Immunomodulatory Therapies
    Mistry, Anoop
    Parry, David
    Matthews, Bipin
    Laws, Philip
    Goodfield, Mark
    Savic, Sinisa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (05) : 429 - 433
  • [5] Hypertrophic pachymeningitis as an unusual presentation of a patient with SLC29A3 spectrum disorder: Considering the use of next-generation sequencing
    Clingo, Mitchell
    Bustamante, Daniel
    Carcamo, Benjamin
    Ross, Steven
    Makoshi, Ziyad
    Moorthy, Chetan
    Chang, Simone M.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (09)
  • [6] Challenges and Successes in Raising a Child With Type 1 Diabetes and Autism Spectrum Disorder: Mixed Methods Study
    Oser, Tamara K.
    Oser, Sean M.
    Parascando, Jessica A.
    Grisolano, Lee Ann
    Krishna, Kanthi Bangalore
    Hale, Daniel E.
    Litchman, Michelle
    Majidi, Shideh
    Haidet, Paul
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (06)